| $350M | ||
| $172M | ||
| $127M | ||
| $109M | ||
| $107M | ||
| $100M |
Buys | $6,423,136 | 8 | 100 |
Sells | $0 | 0 | 0 |
| CULP H LAWRENCE JR | director | 1 | $5M | 0 | $0 | $5M |
| Lobo Kevin | director | 1 | $641,800 | 0 | $0 | $641,800 |
| Arduini Peter J | President and CEO | 1 | $249,827 | 0 | $0 | $249,827 |
| SACCARO JAMES | Chief Financial Officer | 1 | $200,585 | 0 | $0 | $200,585 |
| Jimenez Frank R | GC & Corporate Secretary | 1 | $105,788 | 0 | $0 | $105,788 |
| Hochman Rodney F | director | 1 | $100,365 | 0 | $0 | $100,365 |
| Yang Watkin Phoebe L. | director | 1 | $63,006 | 0 | $0 | $63,006 |
| Stromberg William J | director | 1 | $61,689 | 0 | $0 | $61,689 |
GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women's health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. These include contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – injected into patients for advanced diagnostic imaging applications such as Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and specific ultrasound procedures. Established in 2022, GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.
Over the last 12 months, insiders at GE HealthCare Technologies Inc. have bought $6.42M and sold $0 worth of GE HealthCare Technologies Inc. stock.
On average, over the past 5 years, insiders at GE HealthCare Technologies Inc. have bought $2.19M and sold $5.54M worth of stock each year.
Highest buying activity among insiders over the last 12 months: CULP H LAWRENCE JR (director) — $5M. Lobo Kevin (director) — $641,800. Arduini Peter J (President and CEO) — $249,827.
The last purchase of 10,000 shares for transaction amount of $641,800 was made by Lobo Kevin (director) on 2026‑05‑22.
| 2026-05-22 | Lobo Kevin | director | 10,000 0.0022% | $64.18 | $641,800 | +1.07% | ||
| 2026-05-12 | Hochman Rodney F | director | 1,618 0.0004% | $62.03 | $100,365 | +4.03% | ||
| 2026-05-08 | Yang Watkin Phoebe L. | director | 1,000 0.0002% | $63.01 | $63,006 | +1.99% | ||
| 2026-05-06 | CULP H LAWRENCE JR | director | 80,805 0.0178% | $61.88 | $5M | +4.79% | ||
| 2026-05-06 | Stromberg William J | director | 1,000 0.0002% | $61.69 | $61,689 | +4.79% | ||
| 2026-05-01 | SACCARO JAMES | Chief Financial Officer | 3,310 0.0007% | $60.60 | $200,585 | +5.98% | ||
| 2026-04-30 | Arduini Peter J | President and CEO | 4,169 0.0009% | $59.92 | $249,827 | +6.30% | ||
| 2026-04-30 | Jimenez Frank R | GC & Corporate Secretary | 1,750 0.0004% | $60.45 | $105,788 | +6.30% | ||
| 2025-02-18 | Sale | Newcomb George A. | Chief Accounting Officer | 2,000 0.0004% | $92.54 | $185,080 | -18.54% | |
| 2024-11-06 | Sale | Rott Roland | CEO, Imaging | 3,577 0.0008% | $86.48 | $309,339 | -12.23% | |
| 2024-11-05 | Sale | Rackliffe Philip | CEO, AVS | 900 0.0002% | $87.63 | $78,867 | -13.57% | |
| 2024-08-14 | Sale | Stacherski Kenneth R. | Ch. Supply Chain & Serv. Ofc. | 19,008 0.0042% | $83.22 | $1.58M | -1.41% | |
| 2024-08-07 | Sale | Westrick Thomas J. | CEO, Patient Care Solutions | 2,750 0.0006% | $80.78 | $222,145 | +3.98% | |
| 2024-05-28 | Sale | Kass-Hout Taha | Chief Technology Officer | 3,300 0.0007% | $78.70 | $259,710 | +4.92% | |
| 2024-05-15 | Sale | Makela Jan | CEO, Imaging | 66,955 0.0146% | $81.54 | $5.46M | +0.88% | |
| 2024-05-13 | Sale | Makela Jan | CEO, Imaging | 20,227 0.0045% | $81.57 | $1.65M | +1.98% | |
| 2024-05-01 | Jimenez Frank R | GC & Corporate Secretary | 1,315 0.0003% | $76.52 | $100,624 | +5.67% | ||
| 2023-07-31 | Sale | O'Neill Kevin Michael | CEO, PDx | 15,609 0.0033% | $77.32 | $1.21M | -1.89% | |
| 2023-06-08 | Sale | Rott Roland | CEO, Ultrasound | 2,473 0.0005% | $77.37 | $191,336 | -0.88% | |
| 2023-03-14 | Sale | Makela Jan | CEO, Imaging | 70,629 0.0157% | $77.69 | $5.49M | -0.98% |
| Arduini Peter J | President and CEO | 259424 0.0574% | $17.86M | 1 | 0 | |
| CULP H LAWRENCE JR | director | 151207 0.0335% | $10.41M | 2 | 0 | +8.11% |
| Jimenez Frank R | GC & Corporate Secretary | 93932 0.0208% | $6.47M | 2 | 0 | +5.67% |
| SACCARO JAMES | Chief Financial Officer | 87471 0.0194% | $6.02M | 1 | 0 | |
| Stromberg William J | director | 15330 0.0034% | $1.06M | 1 | 0 | |
| Lobo Kevin | director | 14363 0.0032% | $989,036.18 | 1 | 0 | |
| Yang Watkin Phoebe L. | director | 13702 0.003% | $943,519.72 | 1 | 0 | |
| Hochman Rodney F | director | 1618 0.0004% | $111,415.48 | 1 | 0 | |
| Kass-Hout Taha | Chief Technology Officer | 67300 0.0149% | $4.63M | 0 | 1 | |
| Makela Jan | CEO, Imaging | 63348 0.014% | $4.36M | 0 | 3 | |
| Stacherski Kenneth R. | Ch. Supply Chain & Serv. Ofc. | 38541 0.0085% | $2.65M | 0 | 1 | |
| Rott Roland | CEO, Imaging | 24298 0.0054% | $1.67M | 0 | 2 | |
| O'Neill Kevin Michael | CEO, PDx | 24025 0.0053% | $1.65M | 0 | 1 | |
| Westrick Thomas J. | CEO, Patient Care Solutions | 17509 0.0039% | $1.21M | 0 | 1 | |
| Rackliffe Philip | CEO, AVS | 12715 0.0028% | $875,554.90 | 0 | 1 | |
| Newcomb George A. | Chief Accounting Officer | 7462 0.0017% | $513,833.32 | 0 | 1 |
| Increased Positions | 603 | +41.44% | 44M | +11.31% |
| Decreased Positions | 596 | -40.96% | 22M | -5.72% |
| New Positions | 164 | New | 12M | New |
| Sold Out Positions | 104 | Sold Out | 4M | Sold Out |
| Total Postitions | 1,462 | +0.48% | 406M | +5.6% |
| Vanguard Group Inc | $4.31M | 11.41% | 52.01M | -99,049 | -0.19% | 2025-09-30 |
| Blackrock, Inc. | $3.03M | 8.02% | 36.55M | +697,529 | +1.95% | 2025-09-30 |
| Dodge & Cox | $2.28M | 6.03% | 27.52M | +4M | +16.76% | 2025-09-30 |
| Capital Research Global Investors | $2.07M | 5.48% | 24.97M | +5M | +25.02% | 2025-09-30 |
| State Street Corp | $1.63M | 4.31% | 19.65M | -12,997 | -0.07% | 2025-09-30 |
| Geode Capital Management, Llc | $1M | 2.65% | 12.08M | +130,937 | +1.1% | 2025-09-30 |
| Harris Associates L P | $912,786.00 | 2.42% | 11.02M | +1M | +13.95% | 2025-09-30 |
| Hotchkis & Wiley Capital Management Llc | $698,369.00 | 1.85% | 8.43M | +1M | +17.12% | 2025-09-30 |
| Morgan Stanley | $619,104.00 | 1.64% | 7.48M | -334,202 | -4.28% | 2025-09-30 |
| Invesco Ltd. | $570,725.00 | 1.51% | 6.89M | -1M | -12.92% | 2025-09-30 |